Pneumococcal Vaccine Polyvalent Market - Global Outlook and Forecast 2021-2027

Code: RW00014649806
Market Monitor Global
Dec-2021
Life Sciences
94 Pages

This report contains market size and forecasts of Pneumococcal Vaccine Polyvalent in global, including the following market information:
Global Pneumococcal Vaccine Polyvalent Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Pneumococcal Vaccine Polyvalent Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Pneumococcal Vaccine Polyvalent companies in 2020 (%)
The global Pneumococcal Vaccine Polyvalent market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Pneumococcal Vaccine Polyvalent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pneumococcal Vaccine Polyvalent Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Pneumococcal Vaccine Polyvalent Market Segment Percentages, By Type, 2020 (%)
Prevnar 13
Pneumovax23

Global Pneumococcal Vaccine Polyvalent Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Pneumococcal Vaccine Polyvalent Market Segment Percentages, By Application, 2020 (%)
18 Years and Younger
19 To 64 Years Old
65 Years and Older

Global Pneumococcal Vaccine Polyvalent Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Pneumococcal Vaccine Polyvalent Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pneumococcal Vaccine Polyvalent revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Pneumococcal Vaccine Polyvalent revenues share in global market, 2020 (%)
Key companies Pneumococcal Vaccine Polyvalent sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Pneumococcal Vaccine Polyvalent sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck & Co.
Pfizer

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Pneumococcal Vaccine Polyvalent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pneumococcal Vaccine Polyvalent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pneumococcal Vaccine Polyvalent Overall Market Size
2.1 Global Pneumococcal Vaccine Polyvalent Market Size: 2021 VS 2027
2.2 Global Pneumococcal Vaccine Polyvalent Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pneumococcal Vaccine Polyvalent Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Pneumococcal Vaccine Polyvalent Players in Global Market
3.2 Top Global Pneumococcal Vaccine Polyvalent Companies Ranked by Revenue
3.3 Global Pneumococcal Vaccine Polyvalent Revenue by Companies
3.4 Global Pneumococcal Vaccine Polyvalent Sales by Companies
3.5 Global Pneumococcal Vaccine Polyvalent Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pneumococcal Vaccine Polyvalent Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pneumococcal Vaccine Polyvalent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pneumococcal Vaccine Polyvalent Players in Global Market
3.8.1 List of Global Tier 1 Pneumococcal Vaccine Polyvalent Companies
3.8.2 List of Global Tier 2 and Tier 3 Pneumococcal Vaccine Polyvalent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pneumococcal Vaccine Polyvalent Market Size Markets, 2021 & 2027
4.1.2 Prevnar 13
4.1.3 Pneumovax23
4.2 By Type - Global Pneumococcal Vaccine Polyvalent Revenue & Forecasts
4.2.1 By Type - Global Pneumococcal Vaccine Polyvalent Revenue, 2016-2021
4.2.2 By Type - Global Pneumococcal Vaccine Polyvalent Revenue, 2022-2027
4.2.3 By Type - Global Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
4.3 By Type - Global Pneumococcal Vaccine Polyvalent Sales & Forecasts
4.3.1 By Type - Global Pneumococcal Vaccine Polyvalent Sales, 2016-2021
4.3.2 By Type - Global Pneumococcal Vaccine Polyvalent Sales, 2022-2027
4.3.3 By Type - Global Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
4.4 By Type - Global Pneumococcal Vaccine Polyvalent Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pneumococcal Vaccine Polyvalent Market Size, 2021 & 2027
5.1.2 18 Years and Younger
5.1.3 19 To 64 Years Old
5.1.4 65 Years and Older
5.2 By Application - Global Pneumococcal Vaccine Polyvalent Revenue & Forecasts
5.2.1 By Application - Global Pneumococcal Vaccine Polyvalent Revenue, 2016-2021
5.2.2 By Application - Global Pneumococcal Vaccine Polyvalent Revenue, 2022-2027
5.2.3 By Application - Global Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
5.3 By Application - Global Pneumococcal Vaccine Polyvalent Sales & Forecasts
5.3.1 By Application - Global Pneumococcal Vaccine Polyvalent Sales, 2016-2021
5.3.2 By Application - Global Pneumococcal Vaccine Polyvalent Sales, 2022-2027
5.3.3 By Application - Global Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
5.4 By Application - Global Pneumococcal Vaccine Polyvalent Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Pneumococcal Vaccine Polyvalent Market Size, 2021 & 2027
6.2 By Region - Global Pneumococcal Vaccine Polyvalent Revenue & Forecasts
6.2.1 By Region - Global Pneumococcal Vaccine Polyvalent Revenue, 2016-2021
6.2.2 By Region - Global Pneumococcal Vaccine Polyvalent Revenue, 2022-2027
6.2.3 By Region - Global Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
6.3 By Region - Global Pneumococcal Vaccine Polyvalent Sales & Forecasts
6.3.1 By Region - Global Pneumococcal Vaccine Polyvalent Sales, 2016-2021
6.3.2 By Region - Global Pneumococcal Vaccine Polyvalent Sales, 2022-2027
6.3.3 By Region - Global Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Pneumococcal Vaccine Polyvalent Revenue, 2016-2027
6.4.2 By Country - North America Pneumococcal Vaccine Polyvalent Sales, 2016-2027
6.4.3 US Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.4.4 Canada Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.4.5 Mexico Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Pneumococcal Vaccine Polyvalent Revenue, 2016-2027
6.5.2 By Country - Europe Pneumococcal Vaccine Polyvalent Sales, 2016-2027
6.5.3 Germany Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.5.4 France Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.5.5 U.K. Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.5.6 Italy Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.5.7 Russia Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.5.8 Nordic Countries Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.5.9 Benelux Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Pneumococcal Vaccine Polyvalent Revenue, 2016-2027
6.6.2 By Region - Asia Pneumococcal Vaccine Polyvalent Sales, 2016-2027
6.6.3 China Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.6.4 Japan Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.6.5 South Korea Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.6.6 Southeast Asia Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.6.7 India Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Pneumococcal Vaccine Polyvalent Revenue, 2016-2027
6.7.2 By Country - South America Pneumococcal Vaccine Polyvalent Sales, 2016-2027
6.7.3 Brazil Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.7.4 Argentina Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Sales, 2016-2027
6.8.3 Turkey Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.8.4 Israel Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.8.5 Saudi Arabia Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
6.8.6 UAE Pneumococcal Vaccine Polyvalent Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Merck & Co.
7.1.1 Merck & Co. Corporate Summary
7.1.2 Merck & Co. Business Overview
7.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Major Product Offerings
7.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Sales and Revenue in Global (2016-2021)
7.1.5 Merck & Co. Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Pneumococcal Vaccine Polyvalent Major Product Offerings
7.2.4 Pfizer Pneumococcal Vaccine Polyvalent Sales and Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
8 Global Pneumococcal Vaccine Polyvalent Production Capacity, Analysis
8.1 Global Pneumococcal Vaccine Polyvalent Production Capacity, 2016-2027
8.2 Pneumococcal Vaccine Polyvalent Production Capacity of Key Manufacturers in Global Market
8.3 Global Pneumococcal Vaccine Polyvalent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pneumococcal Vaccine Polyvalent Supply Chain Analysis
10.1 Pneumococcal Vaccine Polyvalent Industry Value Chain
10.2 Pneumococcal Vaccine Polyvalent Upstream Market
10.3 Pneumococcal Vaccine Polyvalent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pneumococcal Vaccine Polyvalent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pneumococcal Vaccine Polyvalent in Global Market
Table 2. Top Pneumococcal Vaccine Polyvalent Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pneumococcal Vaccine Polyvalent Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pneumococcal Vaccine Polyvalent Revenue Share by Companies, 2016-2021
Table 5. Global Pneumococcal Vaccine Polyvalent Sales by Companies, (K Units), 2016-2021
Table 6. Global Pneumococcal Vaccine Polyvalent Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pneumococcal Vaccine Polyvalent Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Pneumococcal Vaccine Polyvalent Product Type
Table 9. List of Global Tier 1 Pneumococcal Vaccine Polyvalent Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumococcal Vaccine Polyvalent Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Pneumococcal Vaccine Polyvalent Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Pneumococcal Vaccine Polyvalent Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Pneumococcal Vaccine Polyvalent Sales (K Units), 2016-2021
Table 15. By Type - Global Pneumococcal Vaccine Polyvalent Sales (K Units), 2022-2027
Table 16. By Application - Global Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Pneumococcal Vaccine Polyvalent Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Pneumococcal Vaccine Polyvalent Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Pneumococcal Vaccine Polyvalent Sales (K Units), 2016-2021
Table 20. By Application - Global Pneumococcal Vaccine Polyvalent Sales (K Units), 2022-2027
Table 21. By Region - Global Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Pneumococcal Vaccine Polyvalent Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Pneumococcal Vaccine Polyvalent Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Pneumococcal Vaccine Polyvalent Sales (K Units), 2016-2021
Table 25. By Region - Global Pneumococcal Vaccine Polyvalent Sales (K Units), 2022-2027
Table 26. By Country - North America Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Pneumococcal Vaccine Polyvalent Sales, (K Units), 2016-2021
Table 29. By Country - North America Pneumococcal Vaccine Polyvalent Sales, (K Units), 2022-2027
Table 30. By Country - Europe Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Pneumococcal Vaccine Polyvalent Sales, (K Units), 2016-2021
Table 33. By Country - Europe Pneumococcal Vaccine Polyvalent Sales, (K Units), 2022-2027
Table 34. By Region - Asia Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Pneumococcal Vaccine Polyvalent Sales, (K Units), 2016-2021
Table 37. By Region - Asia Pneumococcal Vaccine Polyvalent Sales, (K Units), 2022-2027
Table 38. By Country - South America Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Pneumococcal Vaccine Polyvalent Sales, (K Units), 2016-2021
Table 41. By Country - South America Pneumococcal Vaccine Polyvalent Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Sales, (K Units), 2022-2027
Table 46. Merck & Co. Corporate Summary
Table 47. Merck & Co. Pneumococcal Vaccine Polyvalent Product Offerings
Table 48. Merck & Co. Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Pneumococcal Vaccine Polyvalent Product Offerings
Table 51. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Pneumococcal Vaccine Polyvalent Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 53. Global Pneumococcal Vaccine Polyvalent Capacity Market Share of Key Manufacturers, 2019-2021
Table 54. Global Pneumococcal Vaccine Polyvalent Production by Region, 2016-2021 (K Units)
Table 55. Global Pneumococcal Vaccine Polyvalent Production by Region, 2022-2027 (K Units)
Table 56. Pneumococcal Vaccine Polyvalent Market Opportunities & Trends in Global Market
Table 57. Pneumococcal Vaccine Polyvalent Market Drivers in Global Market
Table 58. Pneumococcal Vaccine Polyvalent Market Restraints in Global Market
Table 59. Pneumococcal Vaccine Polyvalent Raw Materials
Table 60. Pneumococcal Vaccine Polyvalent Raw Materials Suppliers in Global Market
Table 61. Typical Pneumococcal Vaccine Polyvalent Downstream
Table 62. Pneumococcal Vaccine Polyvalent Downstream Clients in Global Market
Table 63. Pneumococcal Vaccine Polyvalent Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pneumococcal Vaccine Polyvalent Segment by Type
Figure 2. Pneumococcal Vaccine Polyvalent Segment by Application
Figure 3. Global Pneumococcal Vaccine Polyvalent Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Pneumococcal Vaccine Polyvalent Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Pneumococcal Vaccine Polyvalent Revenue, 2016-2027 (US$, Mn)
Figure 7. Pneumococcal Vaccine Polyvalent Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pneumococcal Vaccine Polyvalent Revenue in 2020
Figure 9. By Type - Global Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 10. By Type - Global Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 11. By Type - Global Pneumococcal Vaccine Polyvalent Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 13. By Application - Global Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 14. By Application - Global Pneumococcal Vaccine Polyvalent Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 16. By Region - Global Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 17. By Country - North America Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 18. By Country - North America Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 19. US Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 24. Germany Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 25. France Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 33. China Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 37. India Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 39. By Country - South America Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 40. Brazil Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Market Share, 2016-2027
Figure 44. Turkey Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Pneumococcal Vaccine Polyvalent Revenue, (US$, Mn), 2016-2027
Figure 48. Global Pneumococcal Vaccine Polyvalent Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Pneumococcal Vaccine Polyvalent by Region, 2020 VS 2027
Figure 50. Pneumococcal Vaccine Polyvalent Industry Value Chain
Figure 51. Marketing Channels

Merck & Co.
Pfizer

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE